SHARE
 
Barbara A. Blodi, MD close
Barbara A. Blodi, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Barbara A. Blodi, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Barbara A. Blodi earned her medical degree from the University of Iowa in Iowa City and completed her residency at the Bascom Palmer Eye Hospital in Miami.

Specialties

Clinics

University Station Clinic
(608) 263-7171 | (800) 323-8942 | Map
UW Health Specialty Clinic - Mauston
(608) 847-7355 | | Map

UW School of Medicine and Public Health

Department of Ophthalmology and Visual Sciences

Professional Certifications and Education

Board Certification Ophthalmology
Fellowship

Medical Retina, Bascom Palmer Eye Institute, Miami, FL

Surgical Retina, University of Michigan Kellogg Eye Center, Ann Arbor, MI


Residency Bascom Palmer Eye Institute, Miami, FL
Internship Good Samaritan Hospital, Phoenix, AZ
Medical School University of Iowa Carver College of Medicine, Iowa City, IA

Languages Spoken

German
Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Scott IU VanVeldhuisen PC Barton F Oden NL Ip MS Blodi BA Worrall M Fish GE Study of Comparative Treatments for Retinal Vein Occlusion 2 Investigator Group. Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol . 2019 Jun 6;
[PubMed ID: 31169862]
Toh H Smolentsev A Bozadjian RV Keeley PW Lockwood MD Sadjadi R Clegg DO Blodi BA Coffey PJ Reese BE Thomson JA Vascular changes in diabetic retinopathy-a longitudinal study in the Nile rat. Lab Invest . 2019 May 17;
[PubMed ID: 31101854]
Holmen IC Aul B Pak JW Trane RM Blodi B Klein M Clemons T Chew E Domalpally A Age-Related Eye Disease Study 2 Research Group. Precursors and Development of Geographic Atrophy with Autofluorescence Imaging: Age-Related Eye Disease Study 2 Report Number 18. Ophthalmol Retina . 2019 Apr 12;
[PubMed ID: 31153849]
Chew EY Clemons TE Jaffe GJ Johnson CA Farsiu S Lad EM Guymer R Rosenfeld P Hubschman JP Constable I Wiley H Singerman LJ Gillies M Comer G Blodi B Eliott D Yan J Bird A Friedlander M Macular Telangiectasia Type 2-Phase 2 CNTF Research Group. Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial. Ophthalmology . 2019 Apr;126(4):540-549
[PubMed ID: 30292541]
Ip MS Oden NL Scott IU VanVeldhuisen PC Blodi BA Ghuman T Baker CW SCORE2 Investigator Group. Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study. JAMA Ophthalmol . 2019 Mar 1;137(3):281-287
[PubMed ID: 30589922]
Peterson JS Rockwell K Jr Scott IU Ip MS VanVeldhuisen PC Blodi BA SCORE2 Investigator Group. LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS. Retina . 2018 May 9;
[PubMed ID: 29746405]
Scott IU VanVeldhuisen PC Ip MS Blodi BA Oden NL Altaweel M Berinstein DM SCORE2 Investigator Group. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial. JAMA Ophthalmol . 2018 Apr 1;136(4):337-345
[PubMed ID: 29476687]
Sadda SR Guymer R Holz FG Schmitz-Valckenberg S Curcio CA Bird AC Blodi BA Bottoni F Chakravarthy U Chew EY Csaky K Danis RP Fleckenstein M Freund KB Grunwald J Hoyng CB Jaffe GJ Liakopoulos S Monés JM Pauleikhoff D Rosenfeld PJ Sarraf D Spaide RF Tadayoni R Tufail A Wolf S Staurenghi G Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology . 2018 Apr;125(4):537-548
[PubMed ID: 29103793]
Scott IU Figueroa MJ Oden NL Ip MS Blodi BA VanVeldhuisen PC SCORE2 Investigator Group. SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion. Am J Ophthalmol . 2017 Dec;184:147-156
[PubMed ID: 29074161]
Scott IU VanVeldhuisen PC Ip MS Blodi BA Oden NL King J Antoszyk AN Peters MA Tolentino M SCORE2 Investigator Group. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4. JAMA Ophthalmol . 2017 Jun 1;135(6):639-649
[PubMed ID: 28492860]
Bressler SB Liu D Glassman AR Blodi BA Castellarin AA Jampol LM Kaufman PL Melia M Singh H Wells JA Diabetic Retinopathy Clinical Research Network. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab. JAMA Ophthalmol . 2017 Jun 1;135(6):558-568
[PubMed ID: 28448655]
Scott IU VanVeldhuisen PC Ip MS Blodi BA Oden NL Awh CC Kunimoto DY Marcus DM Wroblewski JJ King J SCORE2 Investigator Group. Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial. JAMA . 2017 May 23;317(20):2072-2087
[PubMed ID: 28492910]
Holz FG Sadda SR Staurenghi G Lindner M Bird AC Blodi BA Bottoni F Chakravarthy U Chew EY Csaky K Curcio CA Danis R Fleckenstein M Freund KB Grunwald J Guymer R Hoyng CB Jaffe GJ Liakopoulos S Monés JM Oishi A Pauleikhoff D Rosenfeld PJ Sarraf D Spaide RF Tadayoni R Tufail A Wolf S Schmitz-Valckenberg S CAM group. Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings. Ophthalmology . 2017 Apr;124(4):464-478
[PubMed ID: 28109563]
Scott IU VanVeldhuisen PC Ip MS Blodi BA Oden NL Figueroa M Dugel PU SCORE2 Investigator Group. SCORE2 Report 2: Study Design and Baseline Characteristics. Ophthalmology . 2017 Feb;124(2):245-256
[PubMed ID: 27863843]
Domalpally A Danis R Agrón E Blodi B Clemons T Chew E Age-Related Eye Disease Study 2 Research Group. Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11. Ophthalmology . 2016 Nov;123(11):2401-2407
[PubMed ID: 27448832]
Scott IU VanVeldhuisen PC Ip MS Blodi BA Oden NL Figueroa M SCORE2 Investigator Group. SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion. Am J Ophthalmol . 2016 Oct;170:25-31
[PubMed ID: 27450625]
Meyers KJ Liu Z Millen AE Iyengar SK Blodi BA Johnson E Snodderly DM Klein ML Gehrs KM Tinker L Sarto GE Robinson J Wallace RB Mares JA Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration. Ophthalmology . 2015 Nov;122(11):2286-94
[PubMed ID: 26354764]
Aref AA Scott IU Oden NL Ip MS Blodi BA VanVeldhuisen PC SCORE Study Investigator Group. Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15. JAMA Ophthalmol . 2015 Sep;133(9):1022-9
[PubMed ID: 26086920]
Rao P Millen AE Meyers KJ Liu Z Voland R Sondel S Tinker L Wallace RB Blodi BA Binkley N Sarto G Robinson J LeBlanc E Mares JA The Relationship Between Serum 25-Hydroxyvitamin D Levels and Nuclear Cataract in the Carotenoid Age-Related Eye Study (CAREDS), an Ancillary Study of the Women's Health Initiative. Invest Ophthalmol Vis Sci . 2015 Jul;56(8):4221-30
[PubMed ID: 26132781]
Eadie JA Gottlieb JL Ip MS Blodi BA Danis RP Chandra SR Nork TM Altaweel MM Stern-Hogan BS Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina . 2014 Sep-Oct;45(5):394-7
[PubMed ID: 25230402]